Page last updated: 2024-10-26

erythrosine and Central Serous Chorioretinopathy

erythrosine has been researched along with Central Serous Chorioretinopathy in 2 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Central Serous Chorioretinopathy: A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Kang, HG1
Woo, SJ1
Lee, JY1
Cho, HJ1
Ahn, J1
Yang, YS1
Jo, YJ1
Kim, SW1
Kim, SJ1
Sagong, M1
Lee, JJ1
Kang, M1
Park, HS1
Byeon, SH1
Kim, SS1
Kang, SW1
Park, KH1
Lee, CS1
Zhou, X1
Komuku, Y1
Araki, T1
Hozumi, K1
Terasaki, H1
Miki, A1
Kuwayama, S1
Niki, M1
Matsubara, H1
Kinoshita, T1
Nishi, T1
Gomi, F1

Other Studies

2 other studies available for erythrosine and Central Serous Chorioretinopathy

ArticleYear
Pathogenic Risk Factors and Associated Outcomes in the Bullous Variant of Central Serous Chorioretinopathy.
    Ophthalmology. Retina, 2022, Volume: 6, Issue:10

    Topics: Adrenal Cortex Hormones; Central Serous Chorioretinopathy; Choroid Diseases; Fibrin; Fluorescein Ang

2022
A multicentre study of the risk factors associated with recurrence of central serous chorioretinopathy.
    Acta ophthalmologica, 2022, Volume: 100, Issue:8

    Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Female; Fluorescein Angiography; Fluorescein

2022